Swahili
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Adjustment of DOses of NIcotine in Smoking Cessation (ADONIS)

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
Kiungo kimehifadhiwa kwenye clipboard
HaliImekamilika
Wadhamini
Assistance Publique - Hôpitaux de Paris
Washirika
French Health Products Safety Agency

Maneno muhimu

Kikemikali

Nicotine replacement therapies (NRT) have proven efficacy to help smokers quit. However, their effectiveness is low. This study aims to answer the question: Does the dose adjustment of NRT according the saliva concentration of nicotine's main metabolite: cotinine improve their efficacy compared with the lack of dose adjustment (usual care) in smoking patients with smoking related disease condition.

Maelezo

Smokers currently smoking at least 10 cigarettes per day with smoking related diseases are included. They are randomized either to receive standard nicotine replacement therapy (24 h nicotine patch 21, 14, 7 mg/day for one month each, respectively), control arm, or nicotine dose adjustment according their saliva cotinine: dose adaptation arm. In the control arm, at the discretion of the investigators, buccal forms of nicotine replacement therapies are allowed. In both arms, saliva cotinine determinations are performed every 2 weeks for 2 months. In the control arm saliva cotinine results are not communicated to the investigators. In the dose adaptation arm investigators receive saliva cotinine results and should adapt the nicotine doses (mg of nicotine/day) according to baseline (when smoking) saliva cotinine to obtain 100 % substitution. Smokers are assessed at weekly visits after the predetermined quit day for 3 months. Follow up at 6 months. Main outcome measure: sustained abstinence (self reported no smoking and expired air carbon monoxide concentration equal or less than 8 ppm during the last (3rd) month of the treatment phase.

Tarehe

Imethibitishwa Mwisho: 02/28/2007
Iliyowasilishwa Kwanza: 10/05/2005
Uandikishaji uliokadiriwa Uliwasilishwa: 10/05/2005
Iliyotumwa Kwanza: 10/09/2005
Sasisho la Mwisho Liliwasilishwa: 03/27/2008
Sasisho la Mwisho Lilichapishwa: 03/31/2008
Tarehe halisi ya kuanza kwa masomo: 09/30/2005
Tarehe ya Kukamilisha Msingi iliyokadiriwa: 10/31/2007
Tarehe ya Kukamilisha Utafiti: 10/31/2007

Hali au ugonjwa

Smoking Cessation

Uingiliaji / matibabu

Procedure: 1

Drug: 2

Awamu

Awamu 4

Vikundi vya Arm

MkonoUingiliaji / matibabu
Experimental: 1
adaptation of the nicotine patch with salivary cotinine
Procedure: 1
Dose adjustment of nicotine replacement therapies
Other: 2
normal following with a nicotine patch
Drug: 2
normal following with a nicotine patch

Vigezo vya Kustahiki

Zama zinazostahiki Kujifunza 18 Years Kwa 18 Years
Jinsia Inastahiki KujifunzaAll
Hupokea Wajitolea wa AfyaNdio
Vigezo

Inclusion Criteria:

- Age ≥18 years Smoking ≥ 10 cigarettes per day Patients with disease conditions known to be related to smoking: e.g.coronary heart diseases, COPD, lower extremity arterial disease, etc

Exclusion Criteria:

- Smokers whose follow-up during the duration of the study, in a predictable way, cannot be assured.

- smokers having been treated by bupropion ( Zyban) during two months preceding the inclusion

- persons under TSN, neuroleptic, substitute treatments in OPINOIDES, under anticoagulants-non-equilibrating,

- encircled woman

- breast-feeding woman

- Contraindication usual of the TSN

Matokeo

Hatua za Matokeo ya Msingi

1. sustained smoking abstinence [during the study]

Hatua za Matokeo ya Sekondari

1. point prevalence abstinence,craving for tobacco,symptoms of nicotine withdrawal,weight,saliva cotinine concentration,genetic polymorphisms as predictors of therapeutic response and in interaction with nicotine replacement therapies [during the study]

Jiunge na ukurasa
wetu wa facebook

Hifadhidata kamili ya mimea ya dawa inayoungwa mkono na sayansi

  • Inafanya kazi katika lugha 55
  • Uponyaji wa mitishamba unaungwa mkono na sayansi
  • Kutambua mimea kwa picha
  • Ramani ya GPS inayoshirikiana
  • Soma machapisho ya kisayansi yanayohusiana na utafutaji wako
  • Tafuta mimea ya dawa na athari zao
  • Panga maslahi yako na fanya tarehe ya utafiti wa habari, majaribio ya kliniki na ruhusu

Andika dalili au ugonjwa na usome juu ya mimea ambayo inaweza kusaidia, chapa mimea na uone magonjwa na dalili ambazo hutumiwa dhidi yake.
* Habari zote zinategemea utafiti wa kisayansi uliochapishwa

Google Play badgeApp Store badge